ScientaLab

Description

ScientaLab develops a foundation model that predicts human immune response in immunology and inflammation, using multi-disease, multi-tissue data to forecast patient-level responses, support biomarker discovery, and optimize trial design and candidate prioritization.

ScientaLab is located in the Paris ecosystem.

Related

• Orakl OncologyOrakl Oncology builds an AIxBio engine that analyzes multimodal patient data and living biological samples to predict drug responses,…
• Rab DiagnosticsRab Diagnostics develops biomarker tools, assays and the RabCANCER platform to predict antibody–drug conjugate response for pharma…
• Neuralk-AINeuralk-AI provides a tabular foundation model accessible via an API that predicts targets on structured datasets without training or…
• Qubit PharmaceuticalsQubit Pharmaceuticals develops quantum- and AI-driven molecular modeling platforms and drug discovery tools used to design novel drug…
• Jizô AIJizô AI provides a network detection and response (NDR) platform delivering visibility, intelligent detection, rapid investigation and…
• RaidiumRaidium builds an AI-native PACS viewer embedding a foundation model for precision radiology, providing unified tools for detection,…
• IktosIktos builds generative AI and robotics systems for drug discovery, producing platforms for de novo molecule design, retrosynthesis…
• RRiviaRivia provides a unified intelligence layer that ingests and harmonizes fragmented clinical trial data, applies structured trial models,…
• WhiteLab GenomicsWhiteLab Genomics builds AI-driven computational platforms to design and optimize genomic medicines, producing in‑silico modules and…